The trademark application PRALYBRI was filed by Levo Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 14, 2020, and it was registered by office on September 21, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on February 1, 2022.